eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
hammond makes brexit promise to financial services
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
. guerrero scored his first goal on sunday since the suspension, a header in flamengo's 3-2 defeat at chapecoense in the brazilian championship.
.
.
.